Network-based Biomarker for Lung Cancer Diagnosis
Author Information
Author(s): Wang Yu-Chao, Chen Bor-Sen
Primary Institution: National Tsing Hua University
Hypothesis
There is no highly sensitive network-based method for carcinogenesis characterization and diagnosis from the systems perspective.
Conclusion
The network-based biomarker is effective in diagnosing smokers with signs of lung cancer and highlights potential therapeutic targets.
Supporting Evidence
- 40 significant proteins in lung carcinogenesis were identified.
- The network-based biomarker proved effective in diagnosing smokers with signs of lung cancer.
- The method showed a sensitivity of 83.33% and a specificity of 64.71%.
Takeaway
Researchers created a new way to find out if smokers have lung cancer by looking at how proteins in their bodies interact with each other.
Methodology
The study integrated microarray gene expression profiles and protein-protein interaction information to develop a network-based biomarker.
Potential Biases
The method may misclassify smokers without cancer as having cancer due to similarities in molecular patterns.
Limitations
The study's sample size limited the number of proteins included in the network-based biomarker, potentially excluding relevant proteins.
Participant Demographics
The study included 79 smokers with lung cancer and 73 smokers without lung cancer in the primary data set.
Statistical Information
P-Value
< 1e-5
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website